Comments
Drug firm Unichem Laboratories today said its net profit rose by 83.22 cent to Rs 35.07 crore for the quarter ended September 30, 2012, mainly on account of robust sales. The company had posted net profit of Rs 19.14 crore for the quarter ended September 30, 2011.
Total income of the company rose to Rs 264.24 crore for the quarter ended September 30, 2012 compared with Rs 198.83 crore for the corresponding period previous fiscal.
Though formulations form the core of the company’s business, the company also manufactures active pharmaceutical ingredients (APIs or bulk actives).
The firm also manufactures several pharma products that address therapeutic areas like gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti- infectives and pain management among others, it added.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.